Glibenclamide reduces proinflammatory cytokines in an ex vivo model of human endotoxinaemia under hypoxaemic conditions.

D. Schmid,M. Svoboda,Albin Sorgner,Ivana Moravcevic,T. Thalhammer,P. Chiba,T. Möslinger
DOI: https://doi.org/10.1016/j.lfs.2011.08.017
2011-11-07
Life Science
Abstract:
What problem does this paper attempt to address?